Celldex Therapeutics, Inc. Amortization of Debt Discount (Premium)
Celldex Therapeutics, Inc. (CLDX) reported Amortization of Debt Discount (Premium) of $1.64 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2019-03-07
- Celldex Therapeutics, Inc. amortization of debt discount (premium) for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- Celldex Therapeutics, Inc. amortization of debt discount (premium) for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Celldex Therapeutics, Inc. amortization of debt discount (premium) for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- Celldex Therapeutics, Inc. amortization of debt discount (premium) for the quarter ending 2016-03-31 was $1.64M, a 2175.00% increase year-over-year.
- Celldex Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2016 was $1.64M, a 468.75% increase from fiscal 2015.
- Celldex Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2015 was $288.00K, a 300.00% increase from fiscal 2014.
- Celldex Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2014 was $72.00K, a 25.77% decline from fiscal 2013.
- Celldex Therapeutics, Inc. amortization of debt discount (premium) for fiscal 2013 was $97.00K, a 57.08% decline from fiscal 2012.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $0.00 derived: sum of 2 quarters · filed 2019-03-07 | $0.00 derived: sum of 3 quarters · filed 2019-03-07 | $1.64M 10-K · filed 2019-03-07 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $1.64M 10-Q · filed 2017-11-07 | $1.71M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.64M 10-Q · filed 2017-08-08 | $1.71M derived: sum of 3 quarters · filed 2018-03-07 | $1.78M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $1.64M 10-Q · filed 2017-05-09 | $1.71M derived: sum of 2 quarters · filed 2018-03-07 | $1.78M derived: sum of 3 quarters · filed 2018-03-07 | $1.85M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $144.00K derived: sum of 2 quarters · filed 2018-03-07 | $216.00K derived: sum of 3 quarters · filed 2018-03-07 | $288.00K 10-K · filed 2018-03-07 |
| 2015-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $144.00K derived: sum of 2 quarters · filed 2016-11-07 | $216.00K 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $144.00K 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $72.00K 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $72.00K 10-K · filed 2017-03-14 | |||
| 2013-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $41.00K derived: sum of 3 quarters · filed 2016-02-25 | $97.00K 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $41.00K derived: sum of 2 quarters · filed 2014-11-05 | $97.00K 10-Q · filed 2014-11-05 | $154.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $97.00K 10-Q · filed 2014-08-07 | $154.00K derived: sum of 3 quarters · filed 2015-02-24 | $212.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $56.00K 10-Q · filed 2014-05-01 | $113.00K derived: sum of 2 quarters · filed 2015-02-24 | $171.00K derived: sum of 3 quarters · filed 2015-02-24 | $225.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $115.00K derived: sum of 2 quarters · filed 2015-02-24 | $169.00K derived: sum of 3 quarters · filed 2015-02-24 | $226.00K 10-K · filed 2015-02-24 |
| 2012-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $112.00K derived: sum of 2 quarters · filed 2013-11-08 | $169.00K 10-Q · filed 2013-11-08 | $226.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $111.00K 10-Q · filed 2013-08-06 | $168.00K derived: sum of 3 quarters · filed 2014-03-03 | $226.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $57.00K 10-Q · filed 2013-05-03 | $114.00K derived: sum of 2 quarters · filed 2014-03-03 | $172.00K derived: sum of 3 quarters · filed 2014-03-03 | $229.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $115.00K derived: sum of 2 quarters · filed 2014-03-03 | $172.00K derived: sum of 3 quarters · filed 2014-03-03 | $307.00K 10-K · filed 2014-03-03 |
| 2011-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $115.00K derived: sum of 2 quarters · filed 2012-11-02 | $250.00K 10-Q · filed 2012-11-02 | $432.00K derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $192.00K 10-Q · filed 2012-08-09 | $374.00K derived: sum of 3 quarters · filed 2013-03-08 | $556.00K derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | $135.00K 10-Q · filed 2012-05-04 | $317.00K derived: sum of 2 quarters · filed 2013-03-08 | $499.00K derived: sum of 3 quarters · filed 2013-03-08 | |
| 2010-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $364.00K derived: sum of 2 quarters · filed 2013-03-08 | $728.00K 10-K · filed 2013-03-08 | |
| 2010-09-30 | $182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $546.00K 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $364.00K 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $181.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |